Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.
RECRUITINGINTERVENTIONAL

Prospective Study of Detection of Sarcopenia in Clinical Practice for Patient With Ovarian or Endometrial Cancer

Prospective Monocentric Study of the Detection of Sarcopenia in Clinical Practice in Patients With Ovarian or Endometrial Cancer Requiring Systemic Oncological Treatment

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

Prospective monocentric study, non-randomized of the detection of sarcopenia in clinical practice in patients with ovarian or endometrial cancer requiring systemic oncological treatment. main question : Identify the criteria correlated with the presence of sarcopenia (defined by the measurement of the IMS by the CT-X method in L3) among the impedancemetry and the HAS malnutrition criteria. Data collection will be done at 6 months, 12 months after the date of inclusion.

Who May Be Eligible (Plain English)

Who May Qualify: - Patients at least 18 years old - Patient presenting with a diagnosis of cancer of ovarian origin with an indication for chemotherapy - Patient with a diagnosis of endometrial cancer with an indication for chemotherapy - Patient with no diagnosis of other types of cancer in the previous five years - Collection of consent - Patient affiliated to a Social Security scheme Who Should NOT Join This Trial: - Patient with cancer of ovarian origin not requiring chemotherapy treatment - Patient with endometrial cancer not requiring chemotherapy treatment - Discovery of an intercurrent cancer other than skin or cervix cancers. - Patient wearing a Pace maker Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * Patients at least 18 years old * Patient presenting with a diagnosis of cancer of ovarian origin with an indication for chemotherapy * Patient with a diagnosis of endometrial cancer with an indication for chemotherapy * Patient with no diagnosis of other types of cancer in the previous five years * Collection of consent * Patient affiliated to a Social Security scheme Exclusion Criteria: * Patient with cancer of ovarian origin not requiring chemotherapy treatment * Patient with endometrial cancer not requiring chemotherapy treatment * Discovery of an intercurrent cancer other than skin or cervix cancers. * Patient wearing a Pace maker

Treatments Being Tested

DIAGNOSTIC_TEST

Sarcopenia diagnostic test

measurement of impedance and physical tests ("hand grip" dynamometer, walking test), SEFI nutritional intake questionnaire

Locations (1)

Centre Hospitalier Metropole Savoie
Chambéry, Savoie, France